ECOG vs Karnofsky Performance Status Scales
Core Differences
Both ECOG and Karnofsky Performance Status (KPS) scales assess functional status in cancer patients, but they differ fundamentally in scoring direction: ECOG ranges 0-4 where higher scores indicate worse function, while KPS ranges 0-100 where lower scores indicate worse function. 1, 2, 3
Scale Structure
ECOG Performance Status:
Karnofsky Performance Status:
- 11-point scale (0-100 in increments of 10) 3, 5
- Higher numbers = better function 1, 2, 3
- Evaluates three core domains: activity level, work capacity, and self-care abilities 3
Standard Conversion Between Scales
The National Comprehensive Cancer Network uses these equivalent cutoffs for treatment decisions: 1, 2
- Good performance status: ECOG 0-2 = KPS ≥60 1, 2, 6
- Poor performance status: ECOG ≥3 = KPS <60 1, 2, 6
More granular empirical conversion (based on 1,385 patient assessments): 7
This conversion achieved 75% accuracy with strong statistical agreement (weighted kappa 0.84). 7
Clinical Treatment Implications
Chemotherapy Eligibility
Patients eligible for systemic therapy (per NCCN guidelines): 1, 2, 6
Patients who should receive best supportive care only: 1, 2, 6
Intensity of Chemotherapy Regimens
- Reserved exclusively for patients with good performance status (KPS ≥80, roughly ECOG 0-1) 2, 6
- Requires access to frequent toxicity monitoring 2, 6
- Preferred for patients with ECOG 2 or lower KPS scores 2, 6
- More appropriate for those with limited monitoring access 2, 6
Comparative Performance in Clinical Practice
Predictive Validity
ECOG demonstrates superior prognostic discrimination compared to KPS. 4 In a prospective study of 536 lung cancer patients with 1,656 performance status assessments, both scales showed strong correlation (Spearman R = -0.869), but multivariate survival analysis revealed ECOG had better ability to discriminate patients with different prognoses. 4
Reliability
Both scales demonstrate high inter-rater reliability when used by trained oncologists: 8
- KPS inter-observer correlation: K = 0.921 8
- ECOG inter-observer correlation: K = 0.914 8
- Intra-observer reliability even higher (K = 0.960-0.993 for KPS; K = 0.920-0.982 for ECOG) 8
Limitations and Biases
Both scales share critical weaknesses that clinicians must recognize: 3, 9
- Subjective assessment: Both are inherently subjective and open to bias 3, 9
- Age bias: Clinicians assign worse scores to patients >65 years despite no objective difference in physical activity 3
- Less predictive in elderly: Both scales are less predictive of cancer outcomes in older adults 3
- Unidimensional: Neither accounts for multimorbidity, frailty, or cognition 9
- Cause-agnostic: Cannot differentiate whether poor performance stems from disease burden, comorbidities, or treatment toxicity—clinically relevant since disease-related poor performance may improve with effective treatment 3
Practical Recommendations
Use ECOG as the primary scale in clinical practice. 4 The simpler 5-point ECOG scale shows better prognostic discrimination and is easier to apply consistently than the 11-point KPS scale. 4
When interpreting published guidelines or trial eligibility: 1, 2, 7
- Apply the standard conversion: ECOG 0-2 = KPS ≥60 for treatment eligibility 1, 2
- Use the granular conversion table for more precise translation between scales 7
Reassess performance status regularly: 6
- Performance status changes over time and should not be recorded only once 9
- If status deteriorates to ECOG ≥3 or KPS <60 during treatment, discontinue chemotherapy and focus on best supportive care 6
Consider supplementing with additional assessment tools: 9